Latest News in the pharma Industry

Research & Development

Regeneron and Adicet Bio collaborate to discover and develop next-generation engineered immune cell therapeutics

Regeneron and Adicet Bio collaborate to discover and develop next-generation engineered immune cell therapeutics

3 Aug 2016

Companies to pursue "off-the-shelf" cellular therapies in oncology.

Read more 
Catalent Biologics and Zumutor collaborate to develop antibodies with enhanced ADCC Activity

Catalent Biologics and Zumutor collaborate to develop antibodies with enhanced ADCC Activity

2 Aug 2016

The partnership created a fucose knockout GPEx cell line expressing high levels of an anti-HER2 antibody.

Read more 
Selecta Biosciences describes novel approach for improving the efficacy and safety profile of biologic drugs

Selecta Biosciences describes novel approach for improving the efficacy and safety profile of biologic drugs

1 Aug 2016

The data support Selecta’s lead clinical program, showing Selecta’s SVP-Rapamycin (SEL-110) induces antigen-specific immune tolerance and prevents the formation of anti-drug antibodies to biologic drugs, including pegsiticase (for gout) and adalimumab ...

Read more 
EMA accepts for review the Marketing Authorisation Application for sarilumab

EMA accepts for review the Marketing Authorisation Application for sarilumab

1 Aug 2016

Sarilumab is an investigational human monoclonal antibody directed against the IL-6 receptor that is intended for the treatment of adult patients with moderately to severely active rheumatoid arthritis.

Read more 
Sunovion submits NDA for SUN-101/eFlow to FDA for the treatment of patients with COPD

Sunovion submits NDA for SUN-101/eFlow to FDA for the treatment of patients with COPD

31 Jul 2016

If approved, SUN-101/eFlow will be the first nebulized long-acting muscarinic antagonist (LAMA) for the long-term, maintenance treatment of airflow obstruction in patients with COPD.

Read more 
NIH-led researchers develop software that could facilitate drug development

NIH-led researchers develop software that could facilitate drug development

29 Jul 2016

AptaTRACE is the first algorithm that uses the full scope of sequencing data from a large number of selection rounds to capture sequence and structure features of aptamers that bind to the target.

Read more 
Shire’s SHP626 (volixibat) receives FDA fast track designation

Shire’s SHP626 (volixibat) receives FDA fast track designation

29 Jul 2016

Designation is for an investigational treatment of adults who have nonalcoholic steatohepatitis (NASH) with liver fibrosis.

Read more 
New studies suggest relationship between tau pathology and progression of Alzheimer's disease

New studies suggest relationship between tau pathology and progression of Alzheimer's disease

28 Jul 2016

Analysis shows a correlation between tau tangles and cognitive decline in patients living with Alzheimer's disease.

Read more 
Axol Bioscience and Metrion Biosciences announce research collaboration

Axol Bioscience and Metrion Biosciences announce research collaboration

26 Jul 2016

The human cell culture specialists join experts in ion channel research to study human iPSC-derived cardiomyocytes for drug discovery applications.

Read more 
BMS announces new research collaboration with Janssen in immuno-oncology

BMS announces new research collaboration with Janssen in immuno-oncology

26 Jul 2016

The research will evaluate Opdivo and live attenuated double–deleted Listerial monocytogenes cancer immunotherapy

Read more 
Celgene decides against pursuing new indication for its Revlimid

Celgene decides against pursuing new indication for its Revlimid

26 Jul 2016

Data from a Phase III study indicate overall survival showed no benefit of Revlimid.

Read more 
Alzheon presents positive results of ALZ-801 clinical studies

Alzheon presents positive results of ALZ-801 clinical studies

25 Jul 2016

Pharmacokinetic and safety data from Phase Ib studies with ALZ-801, an optimized prodrug of tramiprosate, presented at the Alzheimer's Association International Conference.

Read more